{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:19:19Z","timestamp":1785428359083,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T00:00:00Z","timestamp":1549670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ebiomedicine.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ebiom.2019.02.021","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T10:35:51Z","timestamp":1550054151000},"page":"85-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Evaluation of GDF15 as a therapeutic target of cardiometabolic diseases in human: A Mendelian randomization study"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6233-9144","authenticated-orcid":false,"given":"Ching-Lung","family":"Cheung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn C.B.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip C.M.","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria H.Y.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard M.Y.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ebiom.2019.02.021_bb0005","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.tem.2018.05.002","article-title":"Uniting GDF15 and GFRAL: therapeutic opportunities in obesity and beyond","volume":"29","author":"Mullican","year":"2018","journal-title":"Trends Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ebiom.2019.02.021_bb0010","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrd.2017.241","article-title":"Obesity: GDF15 tells the brain to lose weight","volume":"16","author":"Villanueva","year":"2017","journal-title":"Nat Rev Drug Discov"},{"issue":"7675","key":"10.1016\/j.ebiom.2019.02.021_bb0015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature24042","article-title":"Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15","volume":"550","author":"Hsu","year":"2017","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.ebiom.2019.02.021_bb0020","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nm.4393","article-title":"The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL","volume":"23","author":"Emmerson","year":"2017","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.ebiom.2019.02.021_bb0025","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/nm.4392","article-title":"GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates","volume":"23","author":"Mullican","year":"2017","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.ebiom.2019.02.021_bb0030","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/nm.4394","article-title":"GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand","volume":"23","author":"Yang","year":"2017","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.ebiom.2019.02.021_bb0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrd4279","article-title":"HDL-targeted therapies: progress, failures and future","volume":"13","author":"Kingwell","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"10.1016\/j.ebiom.2019.02.021_bb0040","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1373\/clinchem.2012.190322","article-title":"Clinical and genetic correlates of growth differentiation factor 15 in the community","volume":"58","author":"Ho","year":"2012","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.ebiom.2019.02.021_bb0045","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/hmg\/ddv511","article-title":"Genome-wide DNA methylation study identifies genes associated with the cardiovascular biomarker GDF-15","volume":"25","author":"Ek","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ebiom.2019.02.021_bb0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fgene.2018.00097","article-title":"A meta-analysis of genome-wide association studies of growth differentiation Factor-15 concentration in blood","volume":"9","author":"Jiang","year":"2018","journal-title":"Front Genet"},{"issue":"20","key":"10.1016\/j.ebiom.2019.02.021_bb0055","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1093\/hmg\/ddy271","article-title":"Meta-analysis of genome-wide association studies for height and body mass index in approximately 700000 individuals of European ancestry","volume":"27","author":"Yengo","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"7538","key":"10.1016\/j.ebiom.2019.02.021_bb0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature14132","article-title":"New genetic loci link adipose and insulin biology to body fat distribution","volume":"518","author":"Shungin","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2019.02.021_bb0065","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/s41467-017-01008-2","article-title":"Erratum: large meta-analysis of genome-wide association studies identifies five loci for lean body mass","volume":"8","author":"Zillikens","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2019.02.021_bb0070","doi-asserted-by":"crossref","first-page":"10495","DOI":"10.1038\/ncomms10495","article-title":"New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk","volume":"7","author":"Lu","year":"2016","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.ebiom.2019.02.021_bb0075","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.2337\/db16-1253","article-title":"An expanded genome-wide association study of type 2 diabetes in Europeans","volume":"66","author":"Scott","year":"2017","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.ebiom.2019.02.021_bb0080","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/ng.2274","article-title":"A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance","volume":"44","author":"Manning","year":"2012","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.ebiom.2019.02.021_bb0085","doi-asserted-by":"crossref","first-page":"e1002383","DOI":"10.1371\/journal.pmed.1002383","article-title":"Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: a transethnic genome-wide meta-analysis","volume":"14","author":"Wheeler","year":"2017","journal-title":"PLoS Med"},{"issue":"11","key":"10.1016\/j.ebiom.2019.02.021_bb0090","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Willer","year":"2013","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.ebiom.2019.02.021_bb0095","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/ng.3913","article-title":"Association analyses based on false discovery rate implicate new loci for coronary artery disease","volume":"49","author":"Nelson","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.ebiom.2019.02.021_bb0100","series-title":"bioRxiv","article-title":"An atlas of human and murine genetic influences on osteoporosis","author":"Morris","year":"2018"},{"issue":"6","key":"10.1016\/j.ebiom.2019.02.021_bb0105","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/ije\/dyx034","article-title":"MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data","volume":"46","author":"Yavorska","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"7","key":"10.1016\/j.ebiom.2019.02.021_bb0110","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"issue":"4","key":"10.1016\/j.ebiom.2019.02.021_bb0115","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"issue":"2","key":"10.1016\/j.ebiom.2019.02.021_bb0120","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"5","key":"10.1016\/j.ebiom.2019.02.021_bb0125","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.ebiom.2019.02.021_bb0130","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ije\/dyt179","article-title":"Calculating statistical power in Mendelian randomization studies","volume":"42","author":"Brion","year":"2013","journal-title":"Int J Epidemiol"},{"issue":"412","key":"10.1016\/j.ebiom.2019.02.021_bb0135","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan8732","article-title":"Long-acting MIC-1\/GDF15 molecules to treat obesity: evidence from mice to monkeys","volume":"9","author":"Xiong","year":"2017","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.ebiom.2019.02.021_bb0140","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/jbmr.1538","article-title":"Positive regulation of osteoclastic differentiation by growth differentiation factor 15 upregulated in osteocytic cells under hypoxia","volume":"27","author":"Hinoi","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.ebiom.2019.02.021_bb0145","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2015.124511","article-title":"Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease","volume":"100","author":"Westhrin","year":"2015","journal-title":"Haematologica"},{"issue":"33","key":"10.1016\/j.ebiom.2019.02.021_bb0150","doi-asserted-by":"crossref","first-page":"e4566","DOI":"10.1097\/MD.0000000000004566","article-title":"Growth differentiation factor-15 and white matter hyperintensities in cognitive impairment and dementia","volume":"95","author":"Chai","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"9841","key":"10.1016\/j.ebiom.2019.02.021_bb0155","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.ebiom.2019.02.021_bb0160","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"Evacetrapib and cardiovascular outcomes in high-risk vascular disease","volume":"376","author":"Lincoff","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ebiom.2019.02.021_bb0165","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1308027","article-title":"Loss-of-function mutations in APOC3 and risk of ischemic vascular disease","volume":"371","author":"Jorgensen","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ebiom.2019.02.021_bb0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease","volume":"371","author":"Tg, Hdl Working Group of the Exome Sequencing Project NHL","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ebiom.2019.02.021_bb0175","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa1400283","article-title":"Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia","volume":"373","author":"Gaudet","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2019.02.021_bb0180","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2018.3811","article-title":"Association of multiple biomarkers with risk of all-cause and cause-specific mortality after acute coronary syndromes: a secondary analysis of the PLATO biomarker study","author":"Lindholm","year":"2018","journal-title":"JAMA Cardiol"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419300933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419300933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T10:30:34Z","timestamp":1572777034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419300933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":36,"alternative-id":["S2352396419300933"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.02.021","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of GDF15 as a therapeutic target of cardiometabolic diseases in human: A Mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}